<html><!-- #BeginTemplate "/Templates/news2003.dwt" -->
<head>
<!-- #BeginEditable "doctitle" --> 
<title>Public Citizen</title>
<!-- #EndEditable -->
<meta http-equiv="Content-Type" content="text/html; charset=iso-8859-1">
</head>

<body text="#000000" link="#0000FF" bgcolor="#000099" vlink="#0000FF" alink="#0000FF">
<div align="center">
<center>
<table width="600" bgcolor="#FFFFFF" cellpadding="0" cellspacing="0" align="center">
<tr align="center" valign="top">
<td>
<table border="0" width="100%" cellspacing="0" cellpadding="0" align="center">
<tr valign="middle">
<td align="center" width="15" height="100">&nbsp;</td>
<td align="center" width="340" height="100"> 
                <p align="left"><a href="http://www.commondreams.org"><img border="0" src="../images/newswire.gif" width="340" height="75" alt="Common Dreams NewsCenter" align="bottom"></a> 
              </td>
              <td align="center" width="245" height="100"><a href="http://www.commondreams.org/special/feature.htm"><img src="../special/images/feature.gif" width="230" height="75" border="0"></a></td>
</tr>
<tr valign="middle" align="left" bgcolor="#F4F4E1">
<td height="25" width="15">&nbsp;</td>
              <td bgcolor="#F4F4E1" height="25" width="340"> 
                <p align="left"><b><font face="Arial, Helvetica, sans-serif" size="1">&nbsp;<a href="http://www.commondreams.org/">Home</a> 
                  | <a href="http://www.commondreams.org/newswire.htm">Newswire</a> 
                  |&nbsp;<a href="http://www.commondreams.org/about.htm">About 
                  Us</a> | <a href="http://www.commondreams.org/donate.htm">Donate</a> 
                  </font></b><font size="1" face="Arial, Helvetica, sans-serif"><b> 
                  | <a href="http://www.commondreams.org/email.htm">Sign-Up</a> 
                  | <a href="http://www.commondreams.org/archives.htm">Archives</a></b></font><font color="#000000" size="1" face="Arial"> 
                  </font><font color="#000000" size="1" face="Arial"> </font> 
              </td>
<td align="center" bgcolor="#F4F4E1" height="25" width="245"><font face="Arial, Helvetica, sans-serif" size="1" color="#000099">
<script>
var mydate=new Date()
var theYear=mydate.getFullYear()
var day=mydate.getDay()
var month=mydate.getMonth()
var daym=mydate.getDate()
if (daym<10)
daym="0"+daym
var dayarray=new Array("Sunday","Monday","Tuesday","Wednesday","Thursday","Friday","Saturday")
var montharray=new Array("January","February","March","April","May","June","July","August","September","October","November","December")
document.write(dayarray[day]+", "+montharray[month]+" "+daym+", "+theYear)
</script>
</font></td>
</tr>
</table>
<table border="0" cellpadding="3" cellspacing="0" width="100%">
<tr bgcolor="#E8E8E8" align="right" valign="middle"> 
<td width="600" colspan="5" height="25"> 
     
<div align="right"><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b> 
<a href="http://www.commondreams.org/">Home</a> &gt; <a href="http://www.commondreams.org/community.htm">Progressive 
Community</a> &gt; <a href="http://www.commondreams.org/newswire.htm">NewsWire</a> 
</b></font><b><font face="Verdana, Arial, Helvetica, sans-serif" size="2">&gt; 
For Immediate Release&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></b></div>
</td>
</tr>
<tr> 
<td valign="top" align="left" bgcolor="#E8E8E8" width="15" rowspan="7"> <font face="Arial, Helvetica, sans-serif" size="2"><a href="http://www.commondreams.org/wirearchive.htm">
</a></font> 
<p align="left"><font face="Arial, Helvetica, sans-serif" size="2"><small>
</small></font></p>
<p align="left">&nbsp;</p>
<p>
</td>
<td valign="top" align="left" bgcolor="#FFFFFF" width="20" rowspan="7">&nbsp;</td>
<td valign="bottom" align="left" bgcolor="#FFFFFF" width="90%">
<div align="right"><!-- referralblast starts here -->
<a href="http://www.referralblast.com/cs/com/co1.asp" onclick="window.open('http://www.referralblast.com/cs/com/co1.asp?url=' + location.href,'comWnd','width=440,height=476,scrollbars=yes,menubar=no,resizable=yes'); return false;" target="_blank" onMouseOver="window.status='Send this page to a friend'; return true;" onMouseOut="window.status=''; return true;"><img src="../images/rn-spa-c.gif" alt="Send this page to a friend" width="118" height="23" border="0"></a> 
<!-- referralblast ends here -->
</div>
</td>
<td valign="top" align="left" bgcolor="#FFFFFF" width="20" rowspan="7">&nbsp;</td>
<td valign="top" align="left" bgcolor="#E8E8E8" width="15" rowspan="7">&nbsp; </td>
</tr>
<tr> 
<td valign="top" align="left" width="90%" bgcolor="#FFFFFF"><!-- #BeginEditable "Contact" --> 
                <div align="left"> 
                  <table width="100%" cellpadding="3">
                    <tr> 
                      <td align="left" valign="top" width="35%"><font size="2" face="Arial, Helvetica, sans-serif"><strong>FOR 
                        IMMEDIATE RELEASE<br>
                        </strong>APRIL 1, 2003<br>
                        10:14&nbsp;AM<strong><br>
                        </strong></font></td>
                      <td align="left" valign="top" width="65%"><font size="2" face="Arial, Helvetica, sans-serif"><b>CONTACT: 
                        </b> <b><a href="http://www.citizen.org" target="_new">Public 
                        Citizen</a><br>
                        </b> (202) 588-7742<br>
                        </font> </td>
                    </tr>
                  </table>
                </div>
                <!-- #EndEditable --></td>
</tr>
<tr> 
<td valign="top" align="left" bgcolor="#FFFFFF" width="90%"></td>
</tr>
<tr> 
<td valign="top" align="left" bgcolor="#FFFFFF" width="90%"><font size="4" face="Arial, Helvetica, sans-serif"><b><!-- #BeginEditable "Header" --> 
                <div align="center">Consumer Health Advocates Warn Against Osteoporosis 
                  Drug;<br>
                  <font size="2">Forteo May Lead to Bone Cancer in Humans, Risk 
                  Outweighs Benefit</font></div>
                <!-- #EndEditable --></b></font></td>
</tr>
<tr> 
<td valign="top" align="left" bgcolor="#FFFFFF" width="90%">&nbsp; 
</td>
</tr>
<tr> 
<td valign="top" align="left" bgcolor="#FFFFFF" width="90%"><!-- #BeginEditable "Body" --><font size="2" face="Arial, Helvetica, sans-serif">WASHINGTON 
                - April 1 - Public Citizen’s Health Research Group has recommended 
                that patients not take teriparatide, a drug approved by the U.S. 
                Food and Drug Administration (FDA) in November 2002 for treatment 
                of osteoporosis. Teriparatide, marketed by Eli Lilly under the 
                name Forteo, has led to bone cancer in laboratory animals, a risk 
                that far outweighs the drug’s benefit. </font> 
                <p></p>
                <font face="Arial, Helvetica, sans-serif" size="2">Public Citizen 
                issued a "Do Not Use!" warning in the April issue of Worst Pills, 
                Best Pills News, an online service and monthly newsletter that 
                contains information on drug safety and effectiveness, dangerous 
                dietary supplements, drug-induced symptoms and drug interactions. 
                In the past, Public Citizen’s Do Not Use! warnings have preceded 
                safety-related withdrawals of drugs such as Baycol, Propulsid 
                and Rezulin by months, sometimes years. The Health Research Group 
                has listed more than 200 drugs as Do Not Use! over the past 15 
                years. </font> 
                <p></p>
                <font face="Arial, Helvetica, sans-serif" size="2">In July 2001, 
                Public Citizen recommended against the FDA approval of teriparatide 
                when it learned of the unusually high incidence of osteosarcoma, 
                or malignant bone tumor, in laboratory animals. Although osteosarcomas 
                are generally rare among laboratory animals, rats given teriparatide 
                developed tumors even at the lowest doses tested, and higher exposures 
                shortened the time before tumors developed and the animals died. 
                </font> 
                <p></p>
                <font face="Arial, Helvetica, sans-serif" size="2">The FDA has 
                already mandated a series of warning labels for the drug because 
                of its known risks. The package insert includes a "black box" 
                warning describing the studies on rats. The government also requires 
                that pharmacists distribute patient information leaflets with 
                new and refill prescriptions, a requirement made by the FDA for 
                only a handful of drugs. Also, Eli Lilly has agreed to restrict 
                its promotion of teriparatide, refraining entirely from direct-to-consumer 
                advertising. </font> 
                <p></p>
                <font face="Arial, Helvetica, sans-serif" size="2">"The warnings 
                and restrictions the government has put in place are significant, 
                but the safety hazards are so serious, we do not believe any patients 
                should be taking the risk of ingesting this drug," said Sidney 
                Wolfe, M.D., director of Public Citizen’s Health Research Group. 
                "That’s especially true because there are safer alternatives." 
                </font> 
                <p></p>
                <font face="Arial, Helvetica, sans-serif" size="2">The FDA approved 
                teriparatide to treat osteoporosis in postmenopausal women who 
                are at high risk for fractures and to increase bone mass in men 
                with osteoporosis. There are no data showing that the drug reduces 
                the risk of fractures in men. In women, there are data showing 
                reduced fracture risk, but the reduction is not large, and alendronate, 
                marketed as Fosamax, appears to offer a similar level of risk 
                reduction. Public Citizen recommends that neither men nor women 
                take teriparatide. </font> 
                <p></p>
                <font face="Arial, Helvetica, sans-serif" size="2">Teriparatide 
                is also extremely expensive and must be injected daily. A 30-day 
                supply of teriparatide costs $515.79 at drugstore.com, while a 
                30-day supply of alendronate costs $65.16. </font> 
                <p></p>
                <i><font face="Arial, Helvetica, sans-serif" size="2">The article 
                warning readers to not take teriparatide is on the Worst Pills, 
                Best Pills site at <a href="http://www.worstpills.org" target="_new">www.worstpills.org</a>; 
                reporters can obtain a complimentary subscription to the online 
                newsletter by calling the Public Citizen press office. </font></i><font face="Arial, Helvetica, sans-serif" size="2"> 
                <p align="center">###</p>
                </font><!-- #EndEditable --></td>
</tr>
<tr> 
              <td valign="top" align="left" bgcolor="#FFFFFF" width="90%">
<!-- referralblast starts here -->
<a href="http://www.referralblast.com/cs/com/co1.asp" onclick="window.open('http://www.referralblast.com/cs/com/co1.asp?url=' + location.href,'comWnd','width=440,height=476,scrollbars=yes,menubar=no,resizable=yes'); return false;" target="_blank" onMouseOver="window.status='Send this page to a friend'; return true;" onMouseOut="window.status=''; return true;"><img src="../images/rn-spa-c.gif" alt="Send this page to a friend" width="118" height="23" border="0"></a> 
<!-- referralblast ends here -->
</td>
</tr>
<tr bgcolor="#E8E8E8"> 
<td valign="top" align="center" width="100%" colspan="5" height="15">

<div align="center"><small><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>Common Dreams <a href="http://www.commondreams.org/">NewsCenter</a>&nbsp;is a non-profit news service<br>
 providing breaking news and views for the Progressive Community.</b></font></small> 
</div>
<p align="center"><font face="Verdana, Arial, Helvetica, sans-serif" size="1"><small>The 
press release posted here has been provided to Common Dreams NewsWire by  
one of the many progressive organizations who make up <a href="http://www.commondreams.org/community.htm">America's Progressive Community</a>. 
If 
you wish to comment on this press release or would like more information, 
please contact the organization  directly.<br>
 
</small></font><font size="1" face="Arial">*all times Eastern US (GMT-5:00)</font><font face="Arial, Helvetica, sans-serif" size="2"><small>
</small></font><font face="Arial, Helvetica, sans-serif" size="2"><small><br>
 <br>
</small><b><font size="4">Making News?</font></b><br>
                  Read our <a href="http://www.commondreams.org/newspolicy.htm">Guidelines 
                  for Submitting News Releases</a><br>
                  </font></p>
<div align="center">
<center>
                    <font face="Arial, Helvetica, sans-serif" size="3"><b><font face="Arial, Helvetica, sans-serif" size="1"><a href="http://www.commondreams.org/">Home</a> 
                    | <a href="http://www.commondreams.org/newswire.htm">Newswire</a> 
                    |&nbsp;<a href="http://www.commondreams.org/about.htm">About 
                    Us</a> | <a href="http://www.commondreams.org/donate.htm">Donate</a> 
                    </font></b><font size="1" face="Arial, Helvetica, sans-serif"><b> 
                    | <a href="http://www.commondreams.org/email.htm">Sign-Up</a> 
                    | <a href="http://www.commondreams.org/archives.htm">Archives</a></b></font><font color="#000000" size="1" face="Arial"> 
                    </font><font size="1" face="Arial, Helvetica, sans-serif"><b> 
                    </b></font></font><b><font face="Arial, Helvetica, sans-serif" size="2"><br>
</font></b>
</center>
</div>
<p>
<div align="center"><font face="Arial, Helvetica, sans-serif" size="2"><i>Tell Us What You Think:</i> 
 <a href="mailto:editor@commondreams.org">editor@commondreams.org 
</a><br>
 
</font> 
 


</div>
                <p align="center"> <font face="Arial, Helvetica, sans-serif" size="1">© Copyright 
                  1997-2003 Common Dreams.<br>
 www.commondreams.org</font></p>
                <p>
              </td>
</tr>
</table>
</td>
</tr>
</table>

</center>
</div>
<p align="center">&nbsp;</p>
</body>

<!-- #EndTemplate --></html>
